Trial intelligence / Profile preview

Pain relief and reduction of fallopian tube spasm during and after hysterosalpingography in infertile women

IRCT2017081520258N57Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
May 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine and midazolam in infertility (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Pain relief during hysterosalpingography, Pain relief after hysterosalpingography and 1 more. Started May 2017; status: completed.

02

Drugs

dexmedetomidinemidazolam
03

Conditions

infertility

Beyond the preview

Go deeper on IRCT2017081520258N57.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017081520258N57.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call